Next Article in Journal
Sensitivity of Inner Spacer Thickness Variations for Sub-3-nm Node Silicon Nanosheet Field-Effect Transistors
Next Article in Special Issue
Oxygen-Sensitive Photo- and Radioluminescent Polyurethane Nanoparticles Modified with Octahedral Iodide Tungsten Clusters
Previous Article in Journal
Uniaxial and Coaxial Nanofibers PCL/Alginate or PCL/Gelatine Transport and Release Tamoxifen and Curcumin Affecting the Viability of MCF7 Cell Line
Previous Article in Special Issue
pH-Driven Intracellular Nano-to-Molecular Disassembly of Heterometallic [Au2L2]{Re6Q8} Colloids (L = PNNP Ligand; Q = S2− or Se2−)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 12
Issue 19
10.3390/nano12193350
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy

by
Marina Rodrigues Tavares
1,
Kaplan Kirakci
2,
Nikolay Kotov
1,
Michal Pechar
1,
Kamil Lang
2,
Robert Pola
1,* and
Tomáš Etrych
1
1
Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Heyrovského Náměstí 2, 162 06 Prague 6, Czech Republic
2
Institute of Inorganic Chemistry of the Czech Academy of Sciences, 250 68 Husinec-Řež 1001, Czech Republic
*
Author to whom correspondence should be addressed.
Nanomaterials 2022, 12(19), 3350; https://doi.org/10.3390/nano12193350
Submission received: 19 August 2022 / Revised: 16 September 2022 / Accepted: 19 September 2022 / Published: 26 September 2022
(This article belongs to the Special Issue Functional Nanocomposite Material Based on Metal Atom Clusters)
Browse Figures
Review Reports Versions Notes

Abstract

:
Photo/radiosensitizers, such as octahedral molybdenum clusters (Mo6), have been intensively studied for photodynamic applications to treat various diseases. However, their delivery to the desired target can be hampered by its limited solubility, low stability in physiological conditions, and inappropriate biodistribution, thus limiting the therapeutic effect and increasing the side effects of the therapy. To overcome such obstacles and to prepare photofunctional nanomaterials, we employed biocompatible and water-soluble copolymers based on N-(2-hydroxypropyl)methacrylamide (pHPMA) as carriers of Mo6 clusters. Several strategies based on electrostatic, hydrophobic, or covalent interactions were employed for the formation of polymer-cluster constructs. Importantly, the luminescent properties of the Mo6 clusters were preserved upon association with the polymers: all polymer-cluster constructs exhibited an effective quenching of their excited states, suggesting a production of singlet oxygen (O2(1Δg)) species which is a major factor for a successful photodynamic treatment. Even though the colloidal stability of all polymer-cluster constructs was satisfactory in deionized water, the complexes prepared by electrostatic and hydrophobic interactions underwent severe aggregation in phosphate buffer saline (PBS) accompanied by the disruption of the cohesive forces between the cluster and polymer molecules. On the contrary, the conjugates prepared by covalent interactions notably displayed colloidal stability in PBS in addition to high luminescence quantum yields, suggesting that pHPMA is a suitable nanocarrier for molybdenum cluster-based photosensitizers intended for photodynamic applications.

Graphical Abstract

1. Introduction

Photodynamic therapy (PDT) represents a very promising therapeutic modality which employs the light irradiation as external stimuli to activate compounds, so-called photosensitizers (PS), for the treatment of various malignant tumors. The crucial mechanism of this therapy is based on the interaction of a light-activated PS with molecular oxygen dissolved in the intracellular medium, thus producing reactive oxygen species, e.g., singlet oxygen, O2(1Δg), which can damage critical cellular components. Their cytotoxicity affects cell’s DNA, RNA, lipids, and proteins, resulting in tumor cell destruction. Selection of an appropriate PS is one of the most important factors influencing the efficacy of PDT. Various classes of compounds were described as PS for PDT, e.g., porphyrins, phtalocyanines, indocyanines, or bodipy dyes [1,2,3]. Nevertheless, the pharmacokinetics of PS plays a key role in the PDT treatment efficacy. Indeed, several research groups reported the encapsulation of numerous PS compounds to supramolecular systems, including polymer nanoparticles [4,5] and polymer micelles [4,6], and their controlled delivery. In particular, PS can be physically entrapped into nanoparticles by hydrophobic or electrostatic interactions of PS with biodegradable polymers, namely, poly(glycolic acid) [4,7], poly(lactic acid) [4,7], poly(lactic-co-glycolic acid) [8] and poly(ethylene glycol) [9].
Recently, octahedral molybdenum cluster compounds (Mo6) were reported as relevant photo/radiosensitizers for PDT [10,11,12,13,14], X-ray induced PDT [14,15,16,17,18], and photoinactivation of bacteria [11,19,20,21,22]. Mo6 clusters are nanometer-sized metallic aggregates where the distances between the atoms are similar to those found in corresponding bulk metals, evidencing electron delocalization on the whole cluster. For stabilization, the clusters are surrounded by eight strongly bonded inner ligands (Li), generally halogen (Cl, Br, I), and six apical ligands (La) that can be of either organic or inorganic nature to form a cluster denoted [Mo6Li8La6]n. Upon excitation with UV, blue light, or X-rays, these complexes form long-lived triplet states that relax via a broad red-NIR luminescence. This emission is efficiently quenched by oxygen leading to the formation of O2(1Δg) in high yields [23,24]. Even though a previous study showed the phototoxic activity of Mo6 complexes against the human cervical cancer cell line HeLa [25], their limited solubility and/or low stability in physiological conditions, as well as their lack of tumor selectivity, may result in a systemic toxicity, thus restricting their possible use in PDT [26].
To overcome these shortcomings, we hypothesized that the interaction of Mo6 with a suitable hydrophilic and biocompatible polymer carrier based on N-(2-hydroxypropyl)methacrylamide (pHPMA) may improve both their stability in physiological conditions and also pharmacokinetic properties. The polymer conjugation may prolong half-life in circulation, significantly decrease interaction with serum proteins, promote a superior tumor specific accumulation, and reduce possible adverse effects, thus opening possibilities for their real clinical application. Previous studies have shown that PS molecules bound to pHPMA copolymers accumulate in the tumor via the enhanced permeability and retention (EPR) effect [1], in which the principle relies on the tumor tissues defective blood vessels and leaky vasculature combined with the poor lymphatic drainage, ensuring the O2(1Δg) production in the tumor rather than in healthy tissues [2,27].
In this work, we describe the design, synthesis, and thorough evaluation of physico-chemical properties of HPMA-based polymer-Mo6 constructs. We aimed to explore various strategies, such as covalent or non-covalent interactions, to bind Mo6 clusters to the polymer carriers and to optimize their structures for possible future applications in the field of polymer therapeutics, more specifically on tumor-targeted photodynamic therapy. In this study, the term “complexes” is employed for the non-covalent constructs based on electrostatic and hydrophobic interactions, while the term “conjugates” is used for the constructs prepared by the covalent azide-alkyne “click chemistry” (Figure 1). The relationship between the selected coupling strategy and properties of polymer-Mo6 constructs is studied and described.

2. Materials and Methods

2.1. Materials

1,4-Dioxane, 2,2′-azobisisobutyronitrile (AIBN), 2-cyanopropan-2-yl dithiobenzoate (CTA-AIBN), 2-thiazoline-2-thiol, 2,4,6-trinitrobenzene-1-sulfonic acid (TNBSA), 3-azido-1-propylamine, 4,4′-azobis(4-cyanopentanoic acid) (ACVA), 4-cyano-4-(thiobenzoylthio)pentanoic acid (CTA-ACVA), dimethyl sulfoxide (DMSO), methacryloyl chloride, N,N-diisopropylethylamine (DIPEA), N,N-dimethylacetamide (DMA), phosphate buffered saline (phosphate buffer 0.01M and NaCl 0.154M, pH 7.4) (PBS), and t-butanol were purchased from Sigma-Aldrich (Prague, Czech Republic). 2,2′-Azobis(4-methoxy-2,4-dimethylvaleronitrile) (V-70) was from Fujifilm Wako Chemicals Europe (Neuss, Germany). 3-Amino-1-(11,12-didehydrodibenzo[b,f]azocin-5(6H)-yl)propan-1-one (DBCO-NH2) was from Click Chemistry Tools (Scottsdale, AZ, USA). N-(3-tert-butoxycarbonyl-aminopropyl)methacrylamide (APMA-Boc) was purchased from Polysciences, Inc. (Warrington, PA, USA), and 1-aminopropan-2-ol was from TCI Europe (Zwijndrecht, Belgium). All solvents and chemicals were of analytical grade.

2.2. Synthesis of Monomers

The monomers HPMA [28], 3-methacrylamidopropanoylthiazolidine-2-thione (Ma-AP-TT) [29] and cholest-5en-3β-yl 6-methacrylamido hexanoate (MA-AH-cholesterol) [30] were prepared according to the literature. High Performance Liquid Chromatography (HPLC) analysis was employed to verify the purity of monomers and chain transfer agents. Analysis was performed using a Shimadzu HPLC system with a C18 reversed-phase Chromolith Performance RP-18e column and a diode array detector (Shimadzu SPD-M20A), using water/acetonitrile (gradient of 5–95% v/v acetonitrile) as eluent with 5 mL min−1 flow rate.

2.3. Synthesis of Polymer Precursors P1–P5

Statistical copolymers were prepared by reversible addition–fragmentation chain transfer (RAFT) polymerization of HPMA with respective monomers as follows: MA-AP-TT was employed for P0a, P0b, P1, and P5 copolymers; APMA-Boc for P2 [31]; MA-AH-cholesterol for P3; MA-AH-cholesterol and APMA-Boc for P4. The chain transfer agent CTA-AIBN was used for all precursors except for P2, in which CTA-ACVA was employed instead. Reaction conditions were adapted from our previous studies [32], using a mixture of t-butanol and DMA for all precursors except for P2, in which a mixture of water and dioxane was employed. Dithiobenzoate (DTB) groups originating from CTA were removed by reaction with an excess of AIBN as previously described [33]. For P2 and P4, t-butoxycarbonyl (Boc) groups were removed by heating in distilled water at 150 °C for 1 h [34]. Copolymer P1 with COOH groups along the polymer chain was prepared via hydrolysis of thiazolidine-2-thione (TT) groups of the polymer precursor poly(HPMA-co-MA-AP-TT) in phosphate buffer (pH 8.0). Detailed structures of copolymer precursors P1–P5 are shown in Figure 2, and their physico-chemical characterization is described in Table 1. Detailed synthetic procedures and the ratio between monomers, chain transfer agents, and initiators are described in Supplementary Materials. 1H NMR spectra of polymer precursors P3 and P4 are shown in Supplementary Materials.

2.4. Synthesis of Mo6 Clusters C1–C4

Previously published procedures were employed to prepare Mo6 cluster compounds: [Mo6I8(OCOC4H8PPh3)6]Br4 (C1) [12], Na2[Mo6I8(OPOPh2)6] (C2) [11], Na2[Mo6I8(cholate)6] (C3) [35], and Na2[Mo6I8(N3)6] (C4) [36]. Schematic structures of clusters C1–C4 are shown in Figure 2. For characterization see Table 2.

2.5. Synthesis of Polymer-Cluster Constructs POL1–POL6

Different conjugation strategies were exploited aiming to optimize the constructs’ structure for possible future applications in the field of polymer therapeutics. In this study, the term “complexes” is employed for the non-covalent constructs based on electrostatic (POL1–POL2) and hydrophobic (POL3–POL4) interactions, while the term “conjugates” is used for the constructs using covalent attachment of the Mo6 clusters to the polymer backbone (POL5–POL6). The physico-chemical characterization of polymer-cluster constructs POL1–POL6 is shown in Table 3, and their detailed synthetic procedures are described below.

2.5.1. Electrostatic Non-Covalent–POL1 and POL2

Solutions of the polymer precursor and the cluster, each in 100 µL of methanol, were prepared separately. In case of cluster solution, addition of 10 µL of DMSO was necessary for complete dissolution. Aliquots of 50 µL from each solution were mixed together and vortexed for 10 min. The reaction mixture was added into 1 mL of distilled water and kept under stirring at room temperature for 1 h. Then, methanol was removed under vacuum, and water was added to adjust the volume to 1 mL. The resulting solutions were used for dynamic light scattering (DLS) and quantum yield (QY) measurements. POL1 was composed of P1 (10 mg, 1.3 µmol of -COOH) and cluster C1 (1.3 mg, 0.32 µmol) while POL2 was composed of P2 (10 mg, 2.35 µmol of -NH2) and cluster C2 (3.5 mg, 1.19 µmol).

2.5.2. Hydrophobic Non-Covalent Complexes–POL3 and POL4

The procedure for preparation of POL3 and POL4 was analogous to the one described in 2.5.1., except that the addition of DMSO was not necessary for dissolution of the cluster C3. POL3 was composed of P3 (10 mg) and cluster C3 (2.5 mg) while POL4 was composed of P4 (10 mg) and cluster C3 (2.5 mg).

2.5.3. Covalent Conjugates–POL5–POL6

A solution of P5 (300 mg, 145 µmol of DBCO groups) in dry methanol (2.4 mL) was added into a solution of cluster C4 (49.6 mg, 145 µmol of azide groups) in 0.75 mL of dry methanol under stirring. The reaction mixture was maintained under argon for 30 min; then, it was stirred at 25 °C overnight. Isolation and purification procedures were performed as follows: first, the polymer was precipitated into a mixture of acetone/diethyl ether (1/1) twice. The product was washed with pure diethyl ether and dried under vacuum, affording the polymer-cluster conjugate POL5 (296 mg, 93%). HPLC analysis was performed to control the course of reactions. POL6 was prepared analogously to POL5; however, part of DBCO groups was reacted with 3-azido-1-propylamine via a copper-free alkyne-azide cycloaddition as follows: 3-azido-1-propylamine (1.3 μL, 13.6 μmol) was added to a solution of P5 (150 mg, 72.5 μmol of DBCO groups) in dry DMA (2 mL) followed by cluster C4 (49.6 mg, 145 µmol of azide groups) in 0.75 mL of dry methanol. The reaction mixture was bubbled with argon; then, it was stirred for 3 h at 24 °C. The reaction mixture was diluted with methanol (2 mL) and purified using a Sephadex LH-20 column with methanol elution and UV detection. The conjugate-containing fraction was collected and concentrated under vacuum to 2 mL. The polymer was isolated by precipitation into the mixture of acetone and diethyl ether (2/1; 100 mL) and dried to yield POL6 (136 mg; yield 91%).

2.6. Physico-Chemical and Photophysical Characterization

2.6.1. Size Exclusion Chromatography (SEC)

The number-average molecular weight (Mn), weight-average molecular weight (Mw), and dispersity (Ð) of polymer precursors P1–P5 and polymer-cluster conjugates POL5 and POL6 were determined by a Shimadzu HPLC system equipped with a size exclusion chromatography (SEC) column TSK 3000 SWXL column (Tosoh Bioscience, Tokyo, Japan). Evaluation was carried out using a multi-angle light scattering (MALS) DAWN HELEOS II (Wyatt Technology Co., Santa Barbara, CA, USA), photodiode array SPD-M20A (Shimadzu, Japan) and differential refractometer index Optilab®-rEX (Wyatt Technology Co., Santa Barbara, CA, USA) detectors. The analysis was performed using a mixture of methanol and 0.3 M sodium acetate buffer, pH 6.5 (4/1, v/v) as a mobile phase at a flow rate of 0.5 mL min−1. The ASTRA software (version 8.1, Wyatt Technology Co., Santa Barbara, CA, USA) was used for calculation of Mw and Ð values.

2.6.2. Dynamic Light Scattering (DLS)

The hydrodynamic diameter (Dh) and surface zeta potential (ZP) of all samples was measured using a Nano-ZS instrument (ZEN3600, Malvern, UK) with a laser wavelength of 632.8 nm, and the intensity of the scattered light was detected at an angle θ = 173°. Precursors were dissolved in PBS at 1 mg mL−1. Clusters and polymer-cluster constructs were dissolved in methanol, and aliquots of these solutions were added to deionized water (pH ~ 6) or PBS to obtain the final concentration of 1 mg mL−1; their long-term stability was evaluated. The values were determined as a mean of at least five independent measurements.

2.6.3. UV–VIS Spectrophotometry

UV–VIS spectrophotometry (Specord 205 ST, Analytic Jena AG, Jena, Germany) was used for determination of the content of TT, DBCO, and amine groups. The molar absorption coefficient of ε(TT) = 10,300 L mol−1 cm−1 (λmax = 305 nm) in methanol was used for determination of TT groups in the polymer precursors before hydrolysis (P1) or aminolysis (P5). In the case of DBCO groups, ε(DBCO) = 13,000 L mol−1 cm−1 (λmax = 292 nm) in methanol was employed. The content of amine groups in polymer precursors P2, P4, and polymer-cluster conjugate POL6 was determined using a modified TNBSA assay as published earlier [37]. For P2 and POL6, the solution was prepared in borate buffer (0.1 M Na2B4O7·10H2O, pH 9.3) at the concentration of 2 mg mL−1. An aliquot of 100 μL of this solution was mixed with borate buffer (875 μL) and 0.03 M solution of TNBSA in water (25 μL). The molar absorption coefficient ε (NH2) = 17,200 L mol−1 cm−1 (λmax = 500 nm) was used, and the absorbance was measured after 90 min of incubation. In the case of P4, a similar evaluation method was employed, but the sample was dissolved in a mixture of borate buffer and DMSO (9/1) due to the hydrophobic character of cholesterol moieties [30].

2.6.4. Nuclear Magnetic Resonance (NMR) Spectroscopy

For determination of cholesterol content in polymer precursors P3 and P4, 1H NMR spectra were measured with a Bruker Avance III 600 spectrometer (Bruker, Karlsruhe, Germany) operating at 600.2 MHz using DMSO-d6 as solvent. Typical conditions for measurements of the spectra were as follows: π/2 pulse width 10 µs, relaxation delay 10 s, spectral width 10 kHz, acquisition time 3.21 s, 200 scans, and 5 mm NMR tubes were used. The content of cholesterol moieties statistically distributed along the polymer backbone was assessed using the integral intensities of signals at δ ≈ 4.71 ppm (1 H, OH) and δ ≈ 3.67 ppm (1 H, CH) from the HPMA monomer unit and the integral intensity of the signal at δ ≈ 5.34 ppm (1 H, CH) from C-6 of cholesterol moiety. NMR data for both polymer precursors are shown in the Supplementary Materials, Section S2.

2.6.5. Attenuated Total Reflectance (ATR) Fourier-Transform Infrared (FTIR) Spectroscopy

ATR FTIR spectra were recorded using a Thermo Nicolet Nexus 870 FTIR spectrometer (Bruker, Karlsruhe, Germany) purged with dry air and equipped with a liquid-nitrogen-cooled MCT (mercury cadmium telluride) detector. All the spectra were acquired using a Golden Gate single reflection ATR accessory (Specac Ltd., Orpington, UK) equipped with a diamond internal reflection element. Measurements were performed at room temperature using the following parameters: resolution 4 cm−1 and 256 scans. All data were processed in the OMNIC software (ver. 8.3.103). The atmosphere spectrum was subtracted from the acquired spectra, and then, the resulting spectra were subjected to the baseline and ATR corrections. Measurements were performed for solutions of C4, POL5, and POL6 in distilled water at 0.2 wt. % of Mo6-cluster equivalent.

2.6.6. Luminescence Spectroscopy

Absolute photoluminescence quantum yields and emission spectra in deionized water or PBS were measured using a Quantaurus QY C11347-1 spectrometer (Hamamatsu, Japan). The samples were prepared by adding small aliquots of concentrated methanol solutions of the polymer-cluster constructs to deionized water or PBS to reach the final concentration of 0.1 mg mL−1. All samples were excited at 400 nm. In order to perform measurements under various concentrations of dissolved oxygen, the aqueous solutions of the clusters and the corresponding polymer constructs were saturated with air or argon.

3. Results and Discussion

In order to prevent Mo6 clusters’ aggregation in aqueous solutions, we present novel synthetic strategies for the synthesis of biocompatible polymer-coated Mo6 cluster constructs by employing covalent or non-covalent interactions with various pHPMA copolymers differing in their structure. This study is focused on the physico-chemical and photophysical properties of the polymer-cluster constructs intended as nanomedicines for anti-tumor therapy.

3.1. Synthesis of Polymer Precursors

Controlled RAFT polymerization technique was employed in order to prepare well-defined polymer precursors with an appropriate number of functional groups, such as TT, COOH, NH2, and DBCO moieties, which are used for further chemical modifications.
First, poly(HPMA-co-MA-AP-TT) (P0a) containing reactive TT groups were prepared and subsequently hydrolyzed in phosphate buffer (pH 8.0) to yield poly(HPMA-co-MA-AP-COOH) (P1). Even though much higher amounts of negatively charged groups may be necessary for stronger electrostatic interactions between the polymer and molybdenum molecule, highly, negatively charged systems tend to be captured by the reticuloendothelial system (RES), mainly in the liver and spleen, thus impairing their use for in vivo applications [38]. Therefore, a lower ratio of MA-AP-TT related to HPMA was used for the polymerization of P0a precursor, resulting in copolymers with 1.9 mol. % of final reactive groups and Mw ≈ 18,700 g·mol−1.
Another poly(HPMA-co-MA-AP-TT) (P0b) was prepared, but using a higher ratio of MA-AP-TT related to HPMA, as well as a higher amount of monomers related to CTA and initiator in the reaction mixture, resulting in a precursor containing 10.2 mol. % of reactive TT groups and Mw ≈ 39,200 g mol−1. Here, the respective content of functional groups was chosen aiming to afford a precursor with a higher number of moieties available for further covalent interactions. To prepare P5 containing 8 mol. % of DBCO groups, P0b was reacted with an amine-functionalized DBCO. The copper-free click chemistry approach was selected to avoid the use of copper in further reactions, thus reducing toxicity-related risks and also avoiding time-consuming and complicated purification steps [39].
Higher amounts of positively charged groups on polymer precursors may be necessary to achieve stronger electrostatic interactions with negatively charged molybdenum clusters. Unfortunately, a higher content of amine groups is known to generate toxicity in vitro and in vivo; therefore, the ratio of comonomers was optimized to afford poly(HPMA-co-APMA-Boc) (P2) containing approximately 5.5 mol. % of amine groups.
The introduction of hydrophobic moieties, such as cholesterol or its derivatives, into the structure of the water-soluble polymer carrier switches the character of the polymers to their amphiphilic nature [30,40,41,42]. Such amphiphilic polymers can either self-assemble into the core-shell micellar structures or can form a coating of hydrophobic nanoparticles or liposomes via interaction of cholesterol moiety with hydrophobic compartments of those nanomaterials [43,44]. According to the described procedures [30,40], the amphiphilic polymer precursors P3 and P4 were prepared containing 2.3 and 2.5 mol. % of cholesterol moieties, respectively, and comparable molecular weights around 25,000 g mol−1 with narrow dispersity. For 1H-NMR spectra of P3 and P4, see Figures S1 and S2, respectively. The introduction of certain number of amine groups into the polymer precursor P4 was performed to adjust the negative charge of C3, thus improving the properties of the system for eventual in vivo applications. According to the published data, neutral nanomedicines exhibit more favorable pharmacokinetic properties such as plasma half-life, recognition by RES, and possible adhesion to vascular endothelium [38].
Linear precursors P1 and P2 exhibited hydrodynamic diameters in aqueous solution around 5 nm, typical for HPMA-based polymer random coils, whereas the diameter of P5 was significantly higher (DH ≈ 11 nm) indicating eventual association of the macromolecules due to the presence of the hydrophobic pendant DBCO group and a higher molecular weight of the polymers. As expected, P3 showed the highest hydrodynamic diameter (DH ≈ 40 nm) due to the hydrophobic characteristic of pendant cholesterol moieties, which enable P3 to form micelles in aqueous solution, as already observed in our previous studies of such HPMA copolymers with cholesterol derivatives [40,41]. Nevertheless, positively charged amine moieties distributed along the same polymer backbone (P4) may have contributed to the formation of smaller micelles (DH ≈ 27 nm), probably due to the increased hydrophilicity of the precursor, hence impairing the formation of larger micelles.
Detailed structures and physico-chemical characterization of the polymer precursors P1–P5 are shown in Figure 2 and Table 1, respectively.

3.2. Preparation of Polymer-Cluster Constructs

In this study, several conjugation strategies were exploited aiming to optimize the constructs’ structure for possible future applications in the field of polymer therapeutics. Our initial attempts relied on the use of non-covalent electrostatic and hydrophobic interactions for preparation of the non-covalent constructs (POL1–POL2) and (POL3–POL4), respectively, which are referred to as “complexes”. Afterwards, the covalent attachment of the Mo6 clusters was employed to prepare POL5–POL6, which are called by the term “conjugates”.
The structures of precursors P1–P4 and clusters C1–C3, used for non-covalent complex formation, and precursor P5 and cluster C4, used for preparation of the covalent conjugates, are summarized in Figure 2.
Polymer-cluster complexes POL1 and POL2 were prepared by employing electrostatic interactions between P1 and P2 with the positively and negatively charged Mo6 clusters C1 and C2, respectively. An equimolar ratio between the oppositely charged functional groups of the polymer precursors and clusters was used. Consequently, this resulted in various contents of the clusters within their respective complexes: POL1 (11.5 wt%, cluster charge 4+) and POL2 (25.9 wt%, cluster charge 2−). POL1 exhibited ZP value +9 mV which was slightly lower than that of cluster C1 (+13 mV) as a consequence of the electrostatic complex formation with the negatively charged polymer precursor P1. Although the change in ZP value was relatively low, the formation of the complex POL1 was accompanied with a dramatic change of the hydrodynamic diameter from 48 nm of the cluster C1 (that tends to aggregate in water) to 5 nm of the polymer-coated complex POL1. The cluster–polymer interaction in this particular case enabled to obtain the unimolecular complexes presented in single cluster molecules coated by the hydrophilic copolymer. Most probably, the cluster containing +4 charge is coated with one or two polymer chains affording a slightly positive complex and a small dimension in contrast to huge aggregates of C1 cluster molecules. When the polymer precursor P2 with amine groups was employed for the complex formation, a significant increase in the zeta potential of complex POL2 (+4 mV), reaching almost neutral complex, was observed in comparison to the highly negatively charged cluster C2 (−67 mV) used in complexation. Such behavior indicate that the cluster was successfully modified with the positively charged polymer. Importantly, the hydrodynamic size of complex POL2 was significantly higher (Dh ≈ 30 nm) compared with POL1 (Dh ≈ 5 nm). We hypothesize that this was caused by the presence of much higher content of amino groups on polymer than the carboxyl groups on the cluster. The polymer coated sufficiently the clusters, but one polymer chain was generally involved in the coating of more than one cluster molecule in solution, thus the crosslinking of the polymer-cluster C2 occurred and increased the size.
Another non-covalent method of the polymer-cluster complex preparation explored in this study was based on hydrophobic interactions of polymer precursors P3 and P4, both bearing hydrophobic cholesterol moieties, with the cholate-based cluster C3, affording the polymer-cluster complexes POL3 and POL4, respectively. Loading of 20 wt. % of Mo6 cluster was chosen for both complexes POL3 and POL4. The introduction of amine groups to polymer P4 was performed to verify the influence of the positive charge upon the formation of the hydrophobic complexes (POL3 and POL4). After interaction of precursor P3, bearing cholesterol moieties and neutral charge, with C3 (ZP = −9 mV), the zeta potential of the resulting complex POL3 slightly dropped to −14 mV. Opposite to that, a neutral to slightly positive surface charge (+1 mV) was observed when amine groups were introduced into the structure of POL4, showing the benefit caused by the addition of amino groups to the complex. The hydrodynamic sizes of original P3 and P4 polymers, Dh ≈ 40 and 27 nm, respectively, showed formation of the micelles self-assembled from these amphiphilic copolymers. Importantly, after the complexation with C3, both complexes POL3 and POL4 showed smaller hydrodynamic sizes, Dh = 8.4 and 12 nm, respectively, in comparison to their polymer precursors. We summarize that the observed change in size upon the addition of the hydrophobic moieties containing cluster is most probably caused by disruption of the self-assembled micellar vesicles formed by the amphiphilic polymer precursors and subsequent rearrangement of the polymer chains around the hydrophobic cluster in aqueous solution. In contrast to POL2 and similarly to POL1, both POL3 and POL4 are rather formed by a single molecule of cluster coated by a small number of polymer chains. Physico-chemical characteristics of Mo6 clusters are shown in Table 2.
With respect to the limited colloidal stability of the non-covalent polymer-cluster complexes, which will be further discussed within this manuscript, we evaluated the covalent binding of Mo6 clusters to the polymer carriers as an alternative approach. For this purpose, DBCO groups from polymer precursor P5 were used for the attachment of Mo6 cluster C4 via a copper-free alkyne-azide cycloaddition (“click reaction”), affording stable covalent polymer-cluster conjugates POL5 and POL6. For both conjugates, the content of Mo6 cluster was calculated considering the ratio 1/1 between DBCO groups on polymer precursor and azide groups on cluster moiety.
It is generally known that the highly positively charged systems should be toxic for the body cells and can adhere to the negative vascular endothelium, leading to a lower concentration in the plasma along with an impaired EPR effect [38]. On the other hand, highly negatively charged systems are easily recognized taken up by the immune system, and then stacked in the kidneys. To avoid such effects and potential drawbacks, the ideal surface charge should be neutral or only slightly negative. Therefore, additional amine groups were introduced into the polymer-cluster conjugate POL6 via reaction of the conjugate POL5 with 3-azido-1-propylamine to neutralize the negative charge on the cluster and make the conjugate neutral in charge.
Infrared spectroscopy was used to measure the conversion of the alkyne-azide cycloaddition. The efficiency of C4 conjugation to P5 was determined using the strong asymmetric stretching vibration mode of azide groups [45,46,47]. To assess the amount of unreacted azide groups, a reference was set up as the integral area of the asymmetric stretching vibrational band of azide groups centered at 2056 cm–1 of C4 (0.2 wt% Mo6-cluster in distilled water; Figure 3, dark grey line) [45,46]. This typical complex profile can be attributed to weak Fermi resonance of the vibration with combination tones of C–N stretching vibrations and partly to possible differences in local environments of the six azide groups [47,48]. The azide band’s shift to a lower wavenumber (2056 cm–1) compared to the typical position described in the literature was attributed to the presence of charged molybdenum and iodine atoms in the cluster’s structure [47]. Additionally, the cluster forms a stable colloid in water, and azide groups are involved in H-bonding with water molecules [48] which may contribute to the observed red-shifted position of the band.
After conjugation of C4 with the precursor P5, affording POL5, and further introduction of amine groups along the polymer backbone affording POL6, the asymmetric stretching band intensity of the azide groups greatly decreased (Figure 3, blue and red lines) due to newly formed covalent bond. As the bands’ position remained in the same region, the peak area tool in the OMNIC software was used to compare their intensities in the spectra of POL5 and POL6 using C4 band as a reference. After the conjugation reaction, 9% ± 1% of azide groups remained unreacted for POL5, and similar value was found for POL6. This assessment indicates that the click reaction was successful as majority of the azide groups reacted.
The zeta potential of POL5 conjugate (−17 mV) was similar to the respective cluster C4 (−16 mV). As mentioned above, negatively charged nanoparticles could exhibit unfavorable pharmacokinetic properties after the body injection. Therefore, to avoid such behavior, part of the DBCO groups of polymer precursor P5 was reacted with 3-azido-1-propylamine prior to addition of cluster C4 to compensate, at least partially, the negative zeta potential of the polymer-cluster conjugate. Such combinational approach provided the polymer precursor with 1.5 mol. % of amine groups along the polymer backbone and consequently polymer-cluster conjugate POL6 with zeta potential adjusted to −7 mV, which is much more suitable for future therapeutic application of the developed polymer-cluster conjugates. Both Mw and Dh values proved the formation of polymer-cluster conjugates. The Mw slightly increased for POL5 and POL6 (Mw ≈ 49,500 g mol−1 and 52,000 g mol−1, respectively) when compared to their precursor P5 (Mw ≈ 40,000 g mol−1) upon introduction of Mo6 clusters in the structure. The hydrodynamic size remains similar to that of the other complexes, thus most probably forming the unimolecular complexes presented with a single or low number of cluster molecules. For physico-chemical and photophysical characteristics of polymer-cluster constructs POL1–POL6, see Table 3.
Importantly, we can summarize that we have successfully designed and synthesized several polymer-cluster systems differing in their inner structure and mode of the polymer-cluster interaction or bonding.

3.3. Stability and Photophysical Properties of the Polymer-Cluster Constructs

We further evaluated the colloidal stability and photophysical properties of the polymer-cluster constructs in PBS, a biologically relevant medium. In the case of POL1 and POL2, formed by electrostatic interactions, the complexes were not stable in any manner as the electrostatic interactions were not strong enough to keep the polymer-cluster complexes stable. POL1 and POL2 complexes in PBS immediately formed huge aggregates, and their precipitation was observed quite rapidly after their dissolution. In the case of POL3 and POL4, exploiting the hydrophobic interactions, a slightly better stability in PBS was observed. Nevertheless, aggregates were also formed, suggesting that the hydrophobic polymer-cluster interactions were disrupted in PBS. Consequently, it was not possible to properly perform DLS, SEC or luminescence spectroscopy studies in PBS for any of these non-covalent complexes.
In terms of photophysical properties, the constructs were first studied in deionized water, where they displayed the typical broad emission band of the Mo6 clusters with maxima in the 685–697 nm range (Figure 4). The emissivity was high with luminescence quantum yield ranging from 0.16 for POL1 to 0.49 for POL4 in argon saturated water (see Table 3). The quenching of the emission by oxygen was efficient with a fraction of triplet states quenched by oxygen in an air saturated solution (FT = 1 − ΦL(air)/ΦL(Ar)) of approximately 0.8 for all constructs, indicating good accessibility of the clusters to dissolved oxygen. This feature suggests an effective production of O2(1Δg) which is a major factor for a successful photodynamic treatment. Overall, the luminescent properties of the clusters were preserved upon association with their respective polymers.
In contrast to the non-covalent complexes which were not stable in PBS buffer, covalent polymer-cluster conjugates POL5 and POL6 displayed remarkable stability in PBS. Their hydrodynamic diameter of approximately 7–11 nm and ZP values did not change significantly even after 5 days (see Table 4). Additionally, no drastic changes were observed in the photophysical properties of the conjugates dissolved in PBS in comparison with deionized water solutions, except for slightly red shifted emission maxima and higher quantum yields (Table 4). The photophysical stability of the solutions was evaluated over a five-day period revealing no significant changes in the emission maxima, quantum yields, and oxygen quenching constant, which evidenced the high stability of the photosensitizing system (see Figure 5) in PBS. These features are attractive for photodynamic applications as a reasonable stability of the photosensitizing system is required for an effective PDT.
Taken all together, even though suitable photophysical properties were found for the polymer-cluster complexes, their colloidal stability in PBS does not allow further in vitro and in vivo testing and application. For polymer-cluster conjugates POL5 and POL6 bearing the Mo6 cluster covalently bound to the polymer carrier, a very good stability and photophysical properties were observed. Both size and zeta potential were maintained after several days in PBS and even after months of storage as dried powders; hence, we believe that these conjugates are more suitable for further biomedical applications.

4. Conclusions

This study described the design and synthesis of hydrophilic HPMA-based polymer constructs with Mo6 clusters, potent singlet oxygen photosensitizers, and their structures’ optimization from the chemical and physico-chemical point of view. We investigated three methods of preparation of the constructs using electrostatic, hydrophobic, or covalent interactions between the polymer backbone and cluster moieties. The luminescent properties of the Mo6 clusters were preserved upon association with their respective polymers and all polymer-cluster constructs exhibited a production of O2(1Δg), which is a major factor for a successful photodynamic treatment. The conjugates prepared by covalent interactions, such as the azide-alkyne “click chemistry”, were the best in the series–they possessed a high colloidal stability in PBS and provided high luminescence quantum yields. Moreover, a significant advantage of the synthesis is the fact that copper is completely avoided during the procedure. Results from physico-chemical and photophysical evaluation indicate that the conjugates with Mo6 covalently attached to the polymer backbone are prospective candidates for biological evaluation including measurements of the cytotoxicity effect against selected cancer cells and in vivo experiments using suitable animal tumor models to assess the PDT efficacy of such system.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nano12193350/s1, Detailed procedures for the synthesis of copolymer precursors and NMR spectra of selected precursors.

Author Contributions

M.R.T.—synthesis and characterization of copolymer precursors and polymer-cluster constructs, manuscript preparation and review; K.K.—synthesis and characterization of Mo6 clusters, photoluminescence quantum yields measurements, manuscript review; N.K.—ATR FTIR measurements; M.P.—data analysis, manuscript review; K.L.—coordination of the project (Mo6 cluster part), manuscript review; R.P.—synthesis of copolymer precursors and polymer-cluster constructs, manuscript preparation and review, corresponding author; T.E.—coordination of the project (polymer part), manuscript review. All authors have read and agreed to the published version of the manuscript.

Funding

We gratefully acknowledge the financial support from the Czech Science Foundation (grant No. 21-11688S) and the Ministry of Education, Youth and Sports of the Czech Republic within the Inter-excellence program (project LTAUSA18083).

Data Availability Statement

Not applicable.

Acknowledgments

The authors also acknowledge Petr Kašpárek for his excellent technical assistance and Rafał Łukasz Konefał for NMR measurements.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Maeda, H.; Nakamura, H.; Fang, J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 2013, 65, 71–79. [Google Scholar] [CrossRef] [PubMed]
  2. Fang, J.; Šubr, V.; Islam, W.; Hackbarth, S.; Islam, R.; Etrych, T.; Ulbrich, K.; Maeda, H. N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging. Eur. J. Pharm. Biopharm. 2018, 130, 165–176. [Google Scholar] [CrossRef] [PubMed]
  3. Berg, K.; Selbo, P.K.; Weyergang, A.; Dietze, A.; Prasmickaite, L.; Bonsted, A.; Engesaeter, B.Ø.; Angell-Petersen, E.; Warloe, T.; Frandsen, N.; et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J. Microsc. 2005, 218 Pt 2, 133–147. [Google Scholar] [CrossRef]
  4. Li, L.; Huh, K.M. Polymeric nanocarrier systems for photodynamic therapy. Biomater. Res. 2014, 18, 19. [Google Scholar] [CrossRef] [PubMed]
  5. Chepurna, O.M.; Yakovliev, A.; Ziniuk, R.; Nikolaeva, O.A.; Levchenko, S.M.; Xu, H.; Losytskyy, M.Y.; Bricks, J.L.; Slominskii, Y.L.; Vretik, L.O.; et al. Core–shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions. J. Nanobiotechnol. 2020, 18, 19. [Google Scholar] [CrossRef] [PubMed]
  6. Gibot, L.; Lemelle, A.; Till, U.; Moukarzel, B.; Mingotaud, A.-F.; Pimienta, V.; Saint-Aguet, P.; Rols, M.-P.; Gaucher, M.; Violleau, F.; et al. Polymeric Micelles Encapsulating Photosensitizer: Structure/Photodynamic Therapy Efficiency Relation. Biomacromolecules 2014, 15, 1443–1455. [Google Scholar] [CrossRef] [PubMed]
  7. Lee, Y.-E.K.; Kopelman, R. Polymeric Nanoparticles for Photodynamic Therapy. In Methods in Molecular Biology; Springer: Clifton, NJ, USA, 2011; Volume 726, pp. 151–178. [Google Scholar]
  8. Ricci-Júnior, E.; Marchetti, J.M. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J. Microencapsul. 2006, 23, 523–538. [Google Scholar] [CrossRef]
  9. Weiss, G.J.; Chao, J.; Neidhart, J.D.; Ramanathan, R.K.; Bassett, D.; Neidhart, J.A.; Choi, C.H.J.; Chow, W.; Chung, V.; Forman, S.J.; et al. First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies. Investig. New Drugs 2013, 31, 986–1000. [Google Scholar] [CrossRef]
  10. Brandhonneur, N.; Hatahet, T.; Amela-Cortes, M.; Molard, Y.; Cordier, S.; Dollo, G. Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer. Eur. J. Pharm. Biopharm. 2018, 125, 95–105. [Google Scholar] [CrossRef]
  11. Kirakci, K.; Demel, J.; Hynek, J.; Zelenka, J.; Rumlová, M.; Ruml, T.; Lang, K. Phosphinate Apical Ligands: A Route to a Water-Stable Octahedral Molybdenum Cluster Complex. Inorg. Chem. 2019, 58, 16546–16552. [Google Scholar] [CrossRef]
  12. Kirakci, K.; Zelenka, J.; Rumlová, M.; Cvačka, J.; Ruml, T.; Lang, K. Cationic octahedral molybdenum cluster complexes functionalized with mitochondria-targeting ligands: Photodynamic anticancer and antibacterial activities. Biomater. Sci. 2019, 7, 1386–1392. [Google Scholar] [CrossRef] [PubMed]
  13. Brandhonneur, N.; Boucaud, Y.; Verger, A.; Dumait, N.; Molard, Y.; Cordier, S.; Dollo, G. Molybdenum cluster loaded PLGA nanoparticles as efficient tools against epithelial ovarian cancer. Int. J. Pharm. 2021, 592, 120079. [Google Scholar] [CrossRef] [PubMed]
  14. Smith, C.B.; Days, L.C.; Alajroush, D.R.; Faye, K.; Khodour, Y.; Beebe, S.J.; Holder, A.A. Photodynamic Therapy of Inorganic Complexes for the Treatment of Cancer†. Photochem. Photobiol. 2022, 98, 17–41. [Google Scholar] [CrossRef] [PubMed]
  15. Kirakci, K.; Kubát, P.; Fejfarová, K.; Martinčík, J.; Nikl, M.; Lang, K. X-ray Inducible Luminescence and Singlet Oxygen Sensitization by an Octahedral Molybdenum Cluster Compound: A New Class of Nanoscintillators. Inorg. Chem. 2016, 55, 803–809. [Google Scholar] [CrossRef] [PubMed]
  16. Kirakci, K.; Zelenka, J.; Rumlová, M.; Martinčík, J.; Nikl, M.; Ruml, T.; Lang, K. Octahedral molybdenum clusters as radiosensitizers for X-ray induced photodynamic therapy. J. Mater. Chem. B 2018, 6, 4301–4307. [Google Scholar] [CrossRef] [PubMed]
  17. Kirakci, K.; Pozmogova, T.N.; Protasevich, A.Y.; Vavilov, G.D.; Stass, D.V.; Shestopalov, M.A.; Lang, K. A water-soluble octahedral molybdenum cluster complex as a potential agent for X-ray induced photodynamic therapy. Biomater. Sci. 2021, 9, 2893–2902. [Google Scholar] [CrossRef] [PubMed]
  18. Koncošová, M.; Rumlová, M.; Mikyšková, R.; Reiniš, M.; Zelenka, J.; Ruml, T.; Kirakci, K.; Lang, K. Avenue to X-ray-induced photodynamic therapy of prostatic carcinoma with octahedral molybdenum cluster nanoparticles. J. Mater. Chem. B 2022, 10, 3303–3310. [Google Scholar] [CrossRef]
  19. Felip-León, C.; Arnau del Valle, C.; Pérez-Laguna, V.; Isabel Millán-Lou, M.; Miravet, J.F.; Mikhailov, M.; Sokolov, M.N.; Rezusta-López, A.; Galindo, F. Superior performance of macroporous over gel type polystyrene as a support for the development of photo-bactericidal materials. J. Mater. Chem. B 2017, 5, 6058–6064. [Google Scholar] [CrossRef]
  20. Vorotnikova, N.A.; Alekseev, A.Y.; Vorotnikov, Y.A.; Evtushok, D.V.; Molard, Y.; Amela-Cortes, M.; Cordier, S.; Smolentsev, A.I.; Burton, C.G.; Kozhin, P.M.; et al. Octahedral molybdenum cluster as a photoactive antimicrobial additive to a fluoroplastic. Mater. Sci. Eng. C 2019, 105, 110150. [Google Scholar] [CrossRef] [PubMed]
  21. Kirakci, K.; Nguyen, T.K.N.; Grasset, F.; Uchikoshi, T.; Zelenka, J.; Kubát, P.; Ruml, T.; Lang, K. Electrophoretically Deposited Layers of Octahedral Molybdenum Cluster Complexes: A Promising Coating for Mitigation of Pathogenic Bacterial Biofilms under Blue Light. ACS Appl. Mater. Interfaces 2020, 12, 52492–52499. [Google Scholar] [CrossRef]
  22. López-López, N.; Muñoz Resta, I.; de Llanos, R.; Miravet, J.F.; Mikhaylov, M.; Sokolov, M.N.; Ballesta, S.; García-Luque, I.; Galindo, F. Photodynamic Inactivation of Staphylococcus aureus Biofilms Using a Hexanuclear Molybdenum Complex Embedded in Transparent polyHEMA Hydrogels. ACS Biomater. Sci. Eng. 2020, 6, 6995–7003. [Google Scholar] [CrossRef] [PubMed]
  23. Jackson, J.A.; Turro, C.; Newsham, M.D.; Nocera, D.G. Oxygen quenching of electronically excited hexanuclear molybdenum and tungsten halide clusters. J. Phys. Chem. 1990, 94, 4500–4507. [Google Scholar] [CrossRef]
  24. Kirakci, K.; Kubát, P.; Langmaier, J.; Polívka, T.; Fuciman, M.; Fejfarová, K.; Lang, K. A comparative study of the redox and excited state properties of (nBu4N)2[Mo6X14] and (nBu4N)2[Mo6X8(CF3COO)6] (X = Cl, Br, or I). Dalt. Trans. 2013, 42, 7224. [Google Scholar] [CrossRef]
  25. Kirakci, K.; Kubáňová, M.; Přibyl, T.; Rumlová, M.; Zelenka, J.; Ruml, T.; Lang, K. A Cell Membrane Targeting Molybdenum-Iodine Nanocluster: Rational Ligand Design toward Enhanced Photodynamic Activity. Inorg. Chem. 2022, 61, 5076–5083. [Google Scholar] [CrossRef] [PubMed]
  26. Aubert, T.; Burel, A.; Esnault, M.A.; Cordier, S.; Grasset, F.; Cabello-Hurtado, F. Root uptake and phytotoxicity of nanosized molybdenum octahedral clusters. J. Hazard. Mater. 2012, 219–220, 111–118. [Google Scholar] [CrossRef]
  27. Nakamura, H.; Liao, L.; Hitaka, Y.; Tsukigawa, K.; Subr, V.; Fang, J.; Ulbrich, K.; Maeda, H. Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo. J. Control. Release 2013, 165, 191–198. [Google Scholar] [CrossRef]
  28. Ulbrich, K.; Šubr, V.; Strohalm, J.; Plocová, D.; Jelínková, M.; Říhová, B. Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation. J. Control. Release 2000, 64, 63–79. [Google Scholar] [CrossRef]
  29. Šubr, V.; Ulbrich, K. Synthesis and properties of new N-(2-hydroxypropyl)-methacrylamide copolymers containing thiazolidine-2-thione reactive groups. React. Funct. Polym. 2006, 66, 1525–1538. [Google Scholar] [CrossRef]
  30. Chytil, P.; Etrych, T.; Koňák, Č.; Šírová, M.; Mrkvan, T.; Bouček, J.; Říhová, B.; Ulbrich, K. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. J. Control. Release 2008, 127, 121–130. [Google Scholar] [CrossRef]
  31. Bojarová, P.; Tavares, M.R.; Laaf, D.; Bumba, L.; Petrásková, L.; Konefał, R.; Bláhová, M.; Pelantová, H.; Elling, L.; Etrych, T.; et al. Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3. J. Nanobiotechnol. 2018, 16, 73. [Google Scholar] [CrossRef]
  32. Chytil, P.; Etrych, T.; Kříž, J.; Subr, V.; Ulbrich, K. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation. Eur. J. Pharm. Sci. 2010, 41, 473–482. [Google Scholar] [CrossRef] [PubMed]
  33. Perrier, S.; Takolpuckdee, P.; Mars, C.A. Reversible Addition−Fragmentation Chain Transfer Polymerization: End Group Modification for Functionalized Polymers and Chain Transfer Agent Recovery. Macromolecules 2005, 38, 2033–2036. [Google Scholar] [CrossRef]
  34. Machová, D.; Koziolová, E.; Chytil, P.; Venclíková, K.; Etrych, T.; Janoušková, O. Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers. Eur. J. Pharm. Biopharm. 2018, 131, 141–150. [Google Scholar] [CrossRef]
  35. Kirakci, K.; Zelenka, J.; Křížová, I.; Ruml, T.; Lang, K. Octahedral Molybdenum Cluster Complexes with Optimized Properties for Photodynamic Applications. Inorg. Chem. 2020, 59, 9287–9293. [Google Scholar] [CrossRef] [PubMed]
  36. Kirakci, K.; Kubát, P.; Kučeráková, M.; Šícha, V.; Gbelcová, H.; Lovecká, P.; Grznárová, P.; Ruml, T.; Lang, K. Water-soluble octahedral molybdenum cluster compounds Na2[Mo6I8(N3)6] and Na2[Mo6I8(NCS)6]: Syntheses, luminescence, and in vitro studies. Inorganica Chim. Acta 2016, 441, 42–49. [Google Scholar] [CrossRef]
  37. Etrych, T.; Mrkvan, T.; Chytil, P.; Koňák, Č.; Říhová, B.; Ulbrich, K. N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation. J. Appl. Polym. Sci. 2008, 109, 3050–3061. [Google Scholar] [CrossRef]
  38. Fang, J.; Islam, W.; Maeda, H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv. Drug Deliv. Rev. 2020, 157, 142–160. [Google Scholar] [CrossRef]
  39. Pola, R.; Braunová, A.; Laga, R.; Pechar, M.; Ulbrich, K. Click chemistry as a powerful and chemoselective tool for the attachment of targeting ligands to polymer drug carriers. Polym. Chem. 2014, 5, 1340–1350. [Google Scholar] [CrossRef]
  40. Filippov, S.K.; Chytil, P.; Konarev, P.V.; Dyakonova, M.; Papadakis, C.; Zhigunov, A.; Plestil, J.; Stepanek, P.; Etrych, T.; Ulbrich, K.; et al. Macromolecular HPMA-based nanoparticles with cholesterol for solid-tumor targeting: Detailed study of the inner structure of a highly efficient drug delivery system. Biomacromolecules 2012, 13, 2594–2604. [Google Scholar] [CrossRef]
  41. Chytil, P.; Etrych, T.; Kostka, L.; Ulbrich, K. Hydrolytically Degradable Polymer Micelles for Anticancer Drug Delivery to Solid Tumors. Macromol. Chem. Phys. 2012, 213, 858–867. [Google Scholar] [CrossRef]
  42. Filippov, S.K.; Vishnevetskaya, N.S.; Niebuur, B.J.; Koziolová, E.; Lomkova, E.A.; Chytil, P.; Etrych, T.; Papadakis, C.M. Influence of molar mass, dispersity, and type and location of hydrophobic side chain moieties on the critical micellar concentration and stability of amphiphilic HPMA-based polymer drug carriers. Colloid Polym. Sci. 2017, 295, 1313–1325. [Google Scholar] [CrossRef]
  43. Chytil, P.; Šírová, M.; Kudláčová, J.; Říhová, B.; Ulbrich, K.; Etrych, T. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer–Doxorubicin Drug Conjugates with pH-Triggered Drug Release. Mol. Pharm. 2018, 15, 3654–3663. [Google Scholar] [CrossRef] [PubMed]
  44. Braunová, A.; Chytil, P.; Laga, R.; Šírová, M.; Machová, D.; Parnica, J.; Říhová, B.; Janoušková, O.; Etrych, T. Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties. J. Control. Release 2020, 321, 718–733. [Google Scholar] [CrossRef] [PubMed]
  45. Lieber, E.; Rao, C.N.R.; Hoffman, C.W.W.; Chao, T.S. Infrared Spectra of Organic Azides. Anal. Chem. 1957, 29, 916–918. [Google Scholar] [CrossRef]
  46. Agrell, I.; Klæboe, P.; Pettersson, B.; Svensson, S.; Koskikallio, J.; Kachi, S. The Infra-red Spectra of Some Inorganic Azide Compounds. Acta Chem. Scand. 1971, 25, 2965–2974. [Google Scholar] [CrossRef]
  47. Diana, E.; Gatterer, K.; Kettle, S.F.A. The vibrational spectroscopy of the coordinated azide anion; A theoretical study. Phys. Chem. Chem. Phys. 2016, 18, 414–425. [Google Scholar] [CrossRef]
  48. Gai, X.S.; Coutifaris, B.A.; Brewer, S.H.; Fenlon, E.E. A direct comparison of azide and nitrile vibrational probes. Phys. Chem. Chem. Phys. 2011, 13, 5926–5930. [Google Scholar] [CrossRef] [Green Version]
Nanomaterials 12 03350 g001 550
Figure 1. Schematic representation of non-covalent and covalent interaction approaches employed for binding of Mo6 clusters to polymer precursors; Mo6 cluster not-to-scale.
Figure 1. Schematic representation of non-covalent and covalent interaction approaches employed for binding of Mo6 clusters to polymer precursors; Mo6 cluster not-to-scale.
Nanomaterials 12 03350 g001
Nanomaterials 12 03350 g002 550
Figure 2. Polymer precursors and Mo6 clusters used for non-covalent and covalent interactions: (A) chemical structures of precursors P1–P5; (B) schematic representation of the molecular structure of [M6Li8La6]n cluster and ligands for clusters C1–C4; color coding: molybdenum (blue), iodine (Li: magenta), apical ligands (La: green); hydrogen atoms are omitted for clarity.
Figure 2. Polymer precursors and Mo6 clusters used for non-covalent and covalent interactions: (A) chemical structures of precursors P1–P5; (B) schematic representation of the molecular structure of [M6Li8La6]n cluster and ligands for clusters C1–C4; color coding: molybdenum (blue), iodine (Li: magenta), apical ligands (La: green); hydrogen atoms are omitted for clarity.
Nanomaterials 12 03350 g002
Nanomaterials 12 03350 g003 550
Figure 3. The region of stretching vibrations of the azide groups of cluster C4 and polymer-cluster conjugates POL5 and POL6 in ATR FTIR spectra after subtraction of the corresponding spectrum of water.
Figure 3. The region of stretching vibrations of the azide groups of cluster C4 and polymer-cluster conjugates POL5 and POL6 in ATR FTIR spectra after subtraction of the corresponding spectrum of water.
Nanomaterials 12 03350 g003
Nanomaterials 12 03350 g004 550
Figure 4. Luminescence emission spectra of POL1–POL6 in deionized water: argon-saturated (red curve) and air-saturated (black curve) dispersions. All samples were excited at 400 nm.
Figure 4. Luminescence emission spectra of POL1–POL6 in deionized water: argon-saturated (red curve) and air-saturated (black curve) dispersions. All samples were excited at 400 nm.
Nanomaterials 12 03350 g004
Nanomaterials 12 03350 g005 550
Figure 5. Normalized luminescence emission spectra of POL5 and POL6 in argon-saturated PBS. Solutions were fresh (black curve) or 5 days old (red curve). All samples were excited at 400 nm.
Figure 5. Normalized luminescence emission spectra of POL5 and POL6 in argon-saturated PBS. Solutions were fresh (black curve) or 5 days old (red curve). All samples were excited at 400 nm.
Nanomaterials 12 03350 g005
Table
Table 1. Physico-chemical characteristics of the polymer precursors.
Table 1. Physico-chemical characteristics of the polymer precursors.
Polymer PrecursorStructureFunctional GroupFunctional Groups (mol. %) aMw (g/mol) bÐ bDH
(nm) c
P0a
P0b		poly(HPMA-co-
MA-AP-TT)		TT
(a)
1.9
(b)
10.2
18,500
39,200		1.03
1.04		5.9 ± 0.7
7.4 ± 0.4
P1poly(HPMA-co-
MA-AP-COOH)		COOH1.918,7001.055.3 ± 0.2
P2poly(HPMA-co-APMA)NH25.124,1001.044.9 ± 0.1
P3poly(HPMA-co-
MA-Acap-cholesterol)		cholesterol2.326,4001.0639.9 ± 1.1
P4poly(HPMA-co-APMA-co-
MA-AH-cholesterol)		cholesterol + NH22.5 cholesterol
2.3 NH2		24,6001.0726.8 ± 0.7
P5poly(HPMA-co-
MA-AP-DBCO)		DBCO840,0001.0611.5 ± 0.8
a Contents of TT, DBCO, and NH2 groups were evaluated by UV–VIS spectrophotometry; the content of cholesterol was determined using NMR Spectroscopy. b The weight-average molecular weight (Mw) and dispersity (Ð) were determined using SEC with RI and MALS detection. The analysis was performed using a TSK 3000 SWXL column with methanol/0.3 M sodium acetate buffer, pH 6.5 (4/1, v/v), as a mobile phase. c The mean hydrodynamic diameter (DH) was obtained by DLS with intensity of scattered light detected at angle θ = 173° in PBS.
Table
Table 2. Physico-chemical characteristics of Mo6 clusters.
Table 2. Physico-chemical characteristics of Mo6 clusters.
ClusterFormulaMw (g/mol)DH
(nm) a		ZP (mV) aCharge
C1[Mo6I8(OCOC4H8PPh3)6]Br44084.948.4 ± 5.3134
C2Na2[Mo6I8(OPOCPh2)6]2939.920.2 ± 11.6−67−2
C3Na2[Mo6I8(cholate)6]4082.05.9 ± 1.4−9−2
C4Na2[Mo6I8(N3)6]1889.060.6 ± 15.3−16−2
a The mean hydrodynamic diameter (DH) and zeta potential (ZP) were obtained by DLS measurement with intensity of scattered light detected at angle θ = 173° in deionized water (pH ~ 6).
Table
Table 3. Physico-chemical and photophysical characteristics of polymer-cluster constructs.
Table 3. Physico-chemical and photophysical characteristics of polymer-cluster constructs.
Polymer-Cluster ConstructsPrepared FromType of
Interaction		Mo Cluster (wt%)DH
(nm) a		ZP (mV) aλL (nm) bΦL(Ar) bΦL(air) bFT(air) b
POL1P1 + C1Electrostatic11.55.1 ± 1.196950.160.040.75
POL2P2 + C2Electrostatic25.929.2 ± 9.046900.390.080.79
POL3P3 + C3Hydrophobic20.08.4 ± 2.3−146900.250.050.80
POL4P4 + C3Hydrophobic20.012.0 ± 3.116950.490.090.82
POL5P5 + C4Covalent14.27.3 ± 1.1−176850.250.060.76
POL6P5 + C4 + azide-NH2Covalent14.211.0 ± 0.9−76850.250.060.76
a The mean hydrodynamic diameter (DH) and zeta potential (ZP) were obtained by DLS with intensity of scattered light detected at angle θ = 173° in deionized water (pH ~ 6). b λL is the maximum of luminescence emission bands; ΦL(Ar) and ΦL(air) are the luminescence quantum yields in argon- and air-saturated dispersions, respectively (excitation wavelength was 400 nm); FT(air) is the fraction of the triplet states quenched by oxygen in air saturated solutions: FT(air) = 1 − ΦL(air)/ΦL(Ar).
Table
Table 4. Physico-chemical and photophysical characteristics of fresh solutions of polymer-cluster constructs in PBS and their stability after 5 days.
Table 4. Physico-chemical and photophysical characteristics of fresh solutions of polymer-cluster constructs in PBS and their stability after 5 days.
Polymer-Cluster ConstructsDH
(nm) a		ZP (mV) aλL
(nm) b		ΦL(Ar)ΦL(air)FT(air)
POL5, fresh7.3 ± 1.1−176880.270.060.78
POL5, 5 days old7.9 ± 1.4−156900.250.060.76
POL6, fresh11.0 ± 0.9−76890.270.060.78
POL6, 5 days old14.2 ± 0.1−16900.270.060.78
a The mean hydrodynamic diameter (DH) and zeta potential (ZP) were obtained by DLS with intensity of scattered light detected at angle θ = 173° in PBS. b λL is the maximum of luminescence emission bands; ΦL(Ar) and ΦL(air) are the luminescence quantum yields in argon- and air-saturated dispersions, respectively (excitation wavelength was 400 nm); FT(air) is the fraction of the triplet states quenched by oxygen in air saturated solutions: FT(air) =1 − ΦL(air)/ΦL(Ar).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tavares, M.R.; Kirakci, K.; Kotov, N.; Pechar, M.; Lang, K.; Pola, R.; Etrych, T. Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy. Nanomaterials 2022, 12, 3350. https://doi.org/10.3390/nano12193350

AMA Style

Tavares MR, Kirakci K, Kotov N, Pechar M, Lang K, Pola R, Etrych T. Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy. Nanomaterials. 2022; 12(19):3350. https://doi.org/10.3390/nano12193350

Chicago/Turabian Style

Tavares, Marina Rodrigues, Kaplan Kirakci, Nikolay Kotov, Michal Pechar, Kamil Lang, Robert Pola, and Tomáš Etrych. 2022. "Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy" Nanomaterials 12, no. 19: 3350. https://doi.org/10.3390/nano12193350

APA Style

Tavares, M. R., Kirakci, K., Kotov, N., Pechar, M., Lang, K., Pola, R., & Etrych, T. (2022). Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy. Nanomaterials, 12(19), 3350. https://doi.org/10.3390/nano12193350

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop